FluroTech Ltd. (FLURF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -76.18 Thousand CAD | 48.37% |
| 2022 | -147.57 Thousand CAD | 63.0% |
| 2021 | -398.8 Thousand CAD | 33.02% |
| 2020 | -595.37 Thousand CAD | 65.35% |
| 2019 | -1.71 Million CAD | 46.87% |
| 2018 | -3.23 Million CAD | -2966.22% |
| 2017 | -105.45 Thousand CAD | 45.72% |
| 2016 | -194.28 Thousand CAD | 14.86% |
| 2015 | -228.2 Thousand CAD | 18.12% |
| 2014 | -278.71 Thousand CAD | 13.07% |
| 2013 | -320.63 Thousand CAD | 29.27% |
| 2012 | -453.32 Thousand CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -64.31 Thousand CAD | 15.59% |
| 2024 Q2 | -282.16 Thousand CAD | -338.75% |
| 2023 FY | -76.18 Thousand CAD | 48.37% |
| 2023 Q4 | -76.18 Thousand CAD | 19.67% |
| 2023 Q2 | -81.3 Thousand CAD | 22.41% |
| 2023 Q3 | -94.83 Thousand CAD | -16.64% |
| 2023 Q1 | -104.79 Thousand CAD | 28.98% |
| 2022 Q4 | -147.57 Thousand CAD | 41.28% |
| 2022 Q3 | -251.3 Thousand CAD | 1.71% |
| 2022 Q1 | -247.33 Thousand CAD | 37.98% |
| 2022 FY | -147.57 Thousand CAD | 63.0% |
| 2022 Q2 | -255.66 Thousand CAD | -3.37% |
| 2021 Q1 | -1.8 Million CAD | -203.32% |
| 2021 Q3 | -953.19 Thousand CAD | 51.66% |
| 2021 FY | -398.8 Thousand CAD | 33.02% |
| 2021 Q4 | -398.8 Thousand CAD | 58.16% |
| 2021 Q2 | -1.97 Million CAD | -9.2% |
| 2020 Q3 | -986.67 Thousand CAD | 3.92% |
| 2020 Q4 | -595.37 Thousand CAD | 39.66% |
| 2020 Q1 | -629.61 Thousand CAD | 63.36% |
| 2020 FY | -595.37 Thousand CAD | 65.35% |
| 2020 Q2 | -1.02 Million CAD | -63.1% |
| 2019 Q3 | -3.51 Million CAD | 20.24% |
| 2019 Q4 | -1.71 Million CAD | 51.08% |
| 2019 FY | -1.71 Million CAD | 46.87% |
| 2019 Q1 | -5.11 Million CAD | -58.12% |
| 2019 Q2 | -4.4 Million CAD | 13.88% |
| 2018 Q2 | -7.7 Million CAD | -7409.9% |
| 2018 FY | -3.23 Million CAD | -2966.22% |
| 2018 Q4 | -3.23 Million CAD | 51.69% |
| 2018 Q3 | -6.69 Million CAD | 13.12% |
| 2018 Q1 | -102.59 Thousand CAD | 31.15% |
| 2017 Q4 | -149.01 Thousand CAD | 5.25% |
| 2017 FY | -105.45 Thousand CAD | 45.72% |
| 2017 Q3 | -157.26 Thousand CAD | 0.59% |
| 2017 Q2 | -158.19 Thousand CAD | 15.71% |
| 2017 Q1 | -187.68 Thousand CAD | 3.4% |
| 2016 FY | -194.28 Thousand CAD | 14.86% |
| 2016 Q1 | -226.97 Thousand CAD | 0.54% |
| 2016 Q2 | -203.09 Thousand CAD | 10.52% |
| 2016 Q4 | -194.28 Thousand CAD | 2.79% |
| 2016 Q3 | -199.85 Thousand CAD | 1.6% |
| 2015 Q3 | -245.24 Thousand CAD | 1.68% |
| 2015 Q2 | -249.42 Thousand CAD | 7.19% |
| 2015 FY | -228.2 Thousand CAD | 18.12% |
| 2015 Q4 | -228.2 Thousand CAD | 6.95% |
| 2015 Q1 | -268.74 Thousand CAD | 3.58% |
| 2014 Q3 | -280.3 Thousand CAD | 4.44% |
| 2014 Q4 | -278.71 Thousand CAD | 0.57% |
| 2014 Q2 | -293.32 Thousand CAD | 4.2% |
| 2014 FY | -278.71 Thousand CAD | 13.07% |
| 2014 Q1 | -306.17 Thousand CAD | 4.51% |
| 2013 Q4 | -320.63 Thousand CAD | 3.51% |
| 2013 Q3 | -332.31 Thousand CAD | 13.69% |
| 2013 Q2 | -385 Thousand CAD | 9.93% |
| 2013 Q1 | -427.45 Thousand CAD | 5.71% |
| 2013 FY | -320.63 Thousand CAD | 29.27% |
| 2012 Q2 | -470.66 Thousand CAD | 2.93% |
| 2012 Q1 | -484.85 Thousand CAD | 0.0% |
| 2012 Q4 | -453.32 Thousand CAD | 1.99% |
| 2012 FY | -453.32 Thousand CAD | 0.0% |
| 2012 Q3 | -462.51 Thousand CAD | 1.73% |
| 2011 Q2 | -508.23 Thousand CAD | 4.82% |
| 2011 Q4 | - CAD | 100.0% |
| 2011 Q1 | -533.97 Thousand CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q3 | -485.84 Thousand CAD | 4.41% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | 99.71% |
| Manhattan Scientifics, Inc. | -7000.00 USD | -988.371% |
| Össur hf. | 395.08 Million USD | 100.019% |
| QHSLab, Inc. | 1.72 Million USD | 104.404% |
| Wellstar International, Inc. | 51.36 Million USD | 100.148% |
| Össur hf. | 395.08 Million USD | 100.019% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | 124.133% |
| Aurora Spine Corporation | 1.9 Million USD | 103.994% |
| BrainsWay Ltd. | -10.32 Million USD | 99.262% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 100.514% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 100.42% |
| Vivos Inc. | -1.59 Million USD | 95.215% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 115.633% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 85.917% |
| Zecotek Photonics Inc. | 2.76 Million USD | 102.758% |
| Avitar, Inc. | 5.17 Million USD | 101.473% |
| Nanomix Corporation | 11.38 Million USD | 100.669% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 98.35% |
| Theraclion SA | -5.86 Million EUR | 98.701% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | 1.68 Million USD | 104.516% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 104.73% |
| Lombard Medical, Inc. | 11.49 Million USD | 100.663% |
| ALR Technologies Inc. | 19.14 Million USD | 100.398% |
| Stratec SE | 119.12 Million USD | 100.064% |
| Vycor Medical, Inc. | 1.05 Million USD | 107.235% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 238.533% |
| MicroPort Scientific Corporation | 673.58 Million USD | 100.011% |
| VMS Rehab Systems, Inc. | 133.52 USD | 57159.617% |
| NewCardio, Inc. | 2.41 Million USD | 103.155% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 105.193% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 112.075% |
| Odyssey Group International, Inc. | 2.1 Million USD | 103.614% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 111.9% |
| Wellness Center USA, Inc. | 3.98 Million USD | 101.912% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 100.253% |
| IR-Med Inc. | -606 Thousand USD | 87.428% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 99.447% |
| Polarean Imaging plc | -5.94 Million USD | 98.719% |
| United American Healthcare Corporation | -9.32 Million USD | 99.183% |
| ECGI Holdings, Inc. | 3.17 Million USD | 102.402% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 181.75% |
| Capital Group Holdings, Inc. | -3508.00 USD | -2071.779% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 129.01% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 135.172% |
| Urologix, Inc. | 4.61 Million USD | 101.651% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 101.81% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 102.287% |
| SS Innovations International, Inc. | 1.18 Million USD | 106.427% |
| Qualis Innovations, Inc. | 6671.00 USD | 1242.048% |
| Smith & Nephew plc | 2.77 Billion USD | 100.003% |
| NIOX Group Plc | -23.93 Million USD | 99.682% |
| Fuse Medical, Inc. | 1.75 Million USD | 104.34% |
| Broncus Holding Corporation | -81.42 Million USD | 99.906% |
| Brain Scientific Inc. | 2.11 Million USD | 103.601% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 100.336% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 292.598% |